LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives

Farzaneh Atashrazm,1 Nicolas Dzamko2 1Neuroscience Research Australia, Randwick; 2School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW, Australia Abstract: Major advances in understanding how genetics underlies Parkinson’s disease (PD) have provid...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Atashrazm F, Dzamko N
Format: article
Langue:EN
Publié: Dove Medical Press 2016
Sujets:
Rab
Accès en ligne:https://doaj.org/article/f5632c429f854b89b5083f7a96af03fd
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires